| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Anesthesiology Pamukkale University Faculty of Medicine Denizli Turkey.
Address correspondence to: Dr. Ercan Gürses, Atakent Mahallesi, Esnaf Sitesi Zambak Sokak, No: 8, Yenisehir, 20045 Denizli, Turkey. Phone: +90-258-241 00 34/113; +90-258-373 58 38; Fax: +90-258-373 13 42; E-mail: elgurses{at}pamukkale.edu.tr
| Abstract |
|---|
|
|
|---|
Methods: After Ethics Committee approval and patient informed consent were obtained, epidural catheters were inserted preoperatively at the L34 interspace in 90 ASA physical status III adult patients undergoing lower abdominal surgery. Anesthesia was standardized. Patients were randomly assigned to one of three groups. Group I (T) patients received tramadol 75 mg, Group II (TD) patients received tramadol 75 mg plus droperidol 2.5 mg, and Group III (TC) patients received tramadol 75 mg plus clonidine 150 µg in a total volume of 10 mL administered as a single epidural injection in the postanesthesia care unit. The onset time of analgesia and duration of analgesia, visual analogue pain scores, sedation, nausea scores, vital signs and side effects were recorded.
Results: Duration of analgesia was similar in both the TD and TC groups, and significantly longer than in the T group (P < 0.001). Group TC patients displayed a significant increase in sedation scores and decrease in blood pressure and heart rate when compared with other groups (P < 0.001). No adverse effects were observed in Group TD, while nausea scores were high in both the T and TC groups (P < 0.001). Pain score, respiration rate, and SpO2 values were similar in all study groups.
Conclusion: We conclude that epidural tramadol in combination with droperidol or clonidine prolongs the duration of analgesia; however, droperidol appears to be a better alternative when adverse effects and antiemetic properties are taken into consideration.
| Introduction |
|---|
|
|
|---|
In clinical studies, spinal or epidural administration of non-opioid agents such as clonidine, droperidol, neostigmine, ketamine, midazolam, somatostatine and calcitonin have been shown to provide analgesia without causing motor dysfunction or neurotoxicity.48 Epidural droperidol blocks mainly the fast, and to a lesser extent, the slow sodium channels and inhibits the formation of action potential. Clonidine, which is an alpha2 adrenergic agonist, has an anti-nociceptive effect on a wide dynamic range of neurons and
receptors. Although they cannot provide sufficient analgesia by themselves, when used as adjuncts to low-dose opioids, they decrease adverse effects, and increase the quality and duration of analgesia.914
At present, there is no ideal drug or combination of drugs for postoperative epidural analgesia. The present study was conducted to compare the analgesic and adverse effects (sedation, nausea, vomiting and hemodynamic changes) of epidural tramadol used alone, and the combinations of tramadol-droperidol and tramadol-clonidine.
| Methods |
|---|
|
|
|---|
All patients were taken into the operating room unpremedicated. After standard monitoring with non-invasive blood pressure, electrocardiography and peripheral oxygen saturation (SpO2), administration of Lactated Ringers solution was started. Patients were positioned in the lateral decubitus and a 20-G epidural catheter (Perifix 401, B.Braun, Melsungen AG) was inserted through an 18-gauge Tuohy needle at the L34 interspace. The same anesthesiologist (E.G.) inserted all epidural catheters. After injection of 2 mL 0.5% bupivacaine with 15 µg adrenalin through the epidural catheter as a test dose, the catheter was fixed and the patient was repositioned supine. Induction of anesthesia was achieved with propofol (2 mgkg-1) and cis-atracurium (0.2 mgkg-1). The trachea was intubated and the lungs ventilated mechanically. Anesthesia was maintained with an O2/N2O mixture (50%:50%), isoflurane and cis-atracurium.
After surgery, patients were admitted to the postanesthetic care unit. They were randomly assigned to one of three groups when they stated having pain and were hemodynamically stable. Group I (T) patients received tramadol 75 mg, Group II (TD) received 75 mg tramadol plus 2.5 mg droperidol, and Group III (TC) received 75 mg tramadol plus 150 µg clonidine in a total volume of 10 mL administered as a single epidural injection by an investigator blinded to study group.
The intensity of postoperative pain was measured with the visual analogue scale (VAS). Sedation was monitored on a four-point scale (Table I
)15 and nausea was monitored on a four-point scale (Table II
).16 The onset time of analgesia, duration of analgesia and total tramadol dose were recorded. The onset time of analgesia was defined as the time required to decrease the VAS score control value by 20 mm, and duration of analgesia as the increase of VAS score value by 20 mm. The need for additional tramadol or TC/TD was defined as an increase in the VAS pain score of 20 mm or more. Total tramadol consumption during the last 24 hr is reported in all patients. Vital signs (respiratory rate, SpO2, heart rate, blood pressure), sedation and nausea scores, VAS pain scores and adverse effects were assessed before injection, and at five, ten, 20, 30 min, one, two, three, four, five, six, eight, 12, 16, 20, and 24 hr after epidural injection. In cases of VAS scores 5 cm at rest 30 min after epidural injection, patients were given 1 mgkg-1 meperidine im. When nausea and vomiting were
2, patients were given metoclopramide 10 mg iv. Hypotension, defined as a reduction of the systolic blood pressure > 20%, was treated with the rapid infusion of lactated Ringers solution and iv boluses of ephedrine. All postoperative assessments were made by an investigator blinded to study group.
|
|
0.05 and ß level of 0.2, power analysis indicated that 30 observations would be needed to detect clinically relevant differences in tramadol consumption. A 50% decrease in the tramadol consumption in the treatment groups would be of clinically relevance.17 Intergroup comparison of demographic data was made by Students t test. The three groups were compared by Mann Whitney U test for non-parametric data. Comparison was made by one-way analysis of variance (ANOVA) followed by a Students t test for parametric data. Results were expressed as mean ± standard deviation. A value of P < 0.05 was considered statistically significant. | Results |
|---|
|
|
|---|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
The mean durations of analgesia have been reported as being four to six hours for tramadol alone and 1216 hr for the tramadol-droperidol combination, where the number of daily doses were six to eight for the tramadol alone and one to two for the tramadol-droperidol combination.2,9,16 It has been suggested that the combination of clonidine with an opioid extends the duration of analgesia by two to three times.1,4,10,15,21 Murthy et al.22 have found a lower volume of distribution for epidural tramadol and stated that the half-life was shorter than with iv usage. In the present study, we observed that the addition of clonidine or droperidol to tramadol extends the duration of analgesia by three times on average and, consequently, reduces daily tramadol requirements.
Studies using tramadol and tramadol-droperidol combinations found no significant sedation,2,3,9,16,18 while all studies using clonidine have reported a prominent increase in sedation.1,4,10,15,19 This leads us to believe that the significant increase in sedation observed in the tramadol-clonidine group was due to the addition of clonidine.
Although the studies using epidural clonidine have reported bradycardia and hypotension as the most frequent adverse effects,1,4,10,15,19 no significant hemodynamic adverse effects have been reported with tramadol alone or with the tramadol-droperidol combination.13,12,16,18 We observed a decrease in blood pressure and heart rate from the tenth minute onwards only in the tramadol-clonidine group. This decrease did not require any intervention and no such adverse effect was detected in the other groups.
Low plasma concentrations of tramadol are observed after epidural injection, and these are insufficient to produce an analgesic effect.2 Therefore, despite the lack of a parenteral control group, we believe that the analgesic effect of tramadol was mediated epidurally.
The most frequent side effect of epidural tramadol is nausea. The addition of droperidol to epidural opioids has a strong antiemetic effect.1,4,15,23 In the present study, nausea was the most frequent adverse effect in the tramadol and tramadol-clonidine groups and, since no significant difference was detected between the two groups, we conclude that nausea is probably secondary to tramadol. The absence of nausea in the tramadol-droperidol group is consistent with previous studies and might be related to the antiemetic effect of droperidol.
The main adverse effects of long-term epidural droperidol are sedation, anxiety, panic, suicide and extrapyramidal side effects.1 When used per oral, iv or epidural, droperidol has shown adverse effects such as QT prolongation and/or arrhythmia.2426 The absence of adverse effects in the present study may be secondary to the brief duration of exposure, the low doses used and the small number of patients studied.
The safety of epidural and intrathecal clonidine has been established in several studies.1,10 No local or systemic toxic effects of epidural droperidol have been reported except for excessive sedation.1,8,12 Finally, no systemic or local neurotoxicity has been reported with the epidural injection of tramadol.13,6
In conclusion, our results suggest that the addition of droperidol or clonidine to epidural tramadol provides a shorter onset time and a longer duration of analgesia. Droperidol seems to be a more suitable adjunct when its adverse effects and antiemetic properties are taken into consideration.
Revision received November 4, 2002. Accepted for publication May 27, 2002.
| References |
|---|
|
|
|---|
2 Delilkan AE, Vijayan R. Epidural tramadol for postoperative pain relief. Anaesthesia 1993; 48: 32831.[Medline]
3 Baraka A, Jabour S, Ghabash M, Nader A, Khoury G, Sibai A. A comparison of epidural tramadol and epidural morphine for postoperative analgesia. Can J Anaesth 1993; 40: 30813.
4 Armand S, Langlade A, Boutros A, et al. Meta-analysis of the efficacy of extradural clonidine to relieve postoperative pain: an impossible task. Br J Anaesth 1998; 81: 12634.
5 Hood DD, Eisenach JC, Tuttle RN. Phase I safety assessment of intrathecal neostigmine methylsulphate in humans. Anesthesiology 1995; 82: 33143.[Medline]
6 Tsai YC, Chang PJ, Jou IM. Direct tramadol application on sciatic nerve inhibits spinal somatosensory evoked potentials in rats. Anesth Analg 2001; 92: 154751.
7 Olschewski A, Brau ME, Hempelmann G, Vogel W, Safronov BV. Differential block of fast and slow inactivating tetrodotoxin-sensitive sodium channels by droperidol in spinal dorsal horn neurons. Anesthesiology 2000; 92: 166776.[Medline]
8 Grip G, Svensson BA, Gordh T, Post C Jr, Hartvig P. Histopathology and evaluation of potentiation of morphine-induced antinociception by intrathecal droperidol in the rat. Acta Anaesthesiol Scand 1992; 36: 14552.[Medline]
9 Lewis KS, Han NH. Tramadol: a new centrally acting analgesic. Am J Health Syst Pharm 1997; 54: 64352.
10 Motsch J, Graber E, Ludwig K. Addition of clonidine enhances postoperative analgesia from epidural morphine: a double-blind study. Anesthesiology 1990; 73: 106773.[Medline]
11 Ferrante FM, VadeBoncouer TR. Postoperative Pain Management. New York: Churchill Livingstone; 1993: 641.
12 Naji P, Farschtschian M, Wilder-Smith OH, Wilder-Smith CH. Epidural droperidol and morphine for postoperative pain. Anesth Analg 1990; 70: 5838.
13 Raffa RB, Nayak RK, Liao S, Minn FL. The mechanism(s) of action and pharmacokinetics of tramadol hydrochloride. Rev Contemp Pharmacother 1995; 6: 48597.
14 Desmeules JA, Piguet V, Collart L, Dayer P. Contribution of monoaminergic modulation to the analgesic effect of tramadol. Br J Clin Pharmacol 1996; 41: 712.[Medline]
15 De Kock M, Wiederkher P, Laghmiche A, Scholtes JL. Epidural clonidine used as the sole analgesic agent during and after abdominal surgery. Anesthesiology 1997; 86: 28592.[Medline]
16 Ng KF, Tsui SL, Yang JC, Ho ET. Comparison of tramadol and tramadol/droperidol mixture for patient-controlled analgesia. Can J Anaesth 1997; 44: 8105.
17 Lerman J. Study design in clinical research: sample size estimation and power analysis. Can J Anaesth 1996; 43: 18491.
18 Siddik-Sayyid S, Aouad-Maroun M, Sleiman D, Sfeir M, Baraka A. Epidural tramadol for postoperative pain after cesarean section. Can J Anesth 1999; 46: 7315.
19 Owen MD, Ozsarac O, Sahin S, Uckunkaya N, Kaplan N, Magunaci I. Low-dose clonidine and neostigmine prolong the duration of intrathecal bupivacaine-fentanyl for labor analgesia. Anesthesiology 2000; 92: 3616.[Medline]
20 Eisenach JC, De Kock M, Klimscha W. Alpha2-adrenergic agonists for regional anesthesia. A clinical review of clonidine (1984-1995). Anesthesiology 1996; 85: 65574.[Medline]
21 Curatolo M, Schnider TW, Petersen-Felix S, et al. A direct search procedure to optimize combinations of epidural bupivacaine, fentanyl, and clonidine for postoperative analgesia. Anesthesiology 2000; 92: 32537.[Medline]
22 Murthy BV, Pandya KS, Booker PD, Murray A, Lintz W, Terlinden R. Pharmacokinetics of tramadol in children after i.v. or caudal epidural administration. Br J Anaesth 2000; 84: 3469.
23 Horta ML, Ramos L, Gonçalves ZR. The inhibition of epidural morphine-induced pruritus by epidural droperidol. Anesth Analg 2000; 90: 63841.
24 Bailey P, Norton R, Karan S. The FDA droperidol warning: is it justified? (Letter). Anesthesiology 2002; 97: 2889.
25 Kantor GS. Arrhythmia risk of antiemetic agents. Anesthesiology 2002; 97: 286.[Medline]
26 Lischke V, Behne M, Doelken P, Schledt U, Probst S, Vettermann J. Droperidol causes a dose-dependent prolongation of the QT interval. Anesth Analg 2002; 79: 983 (abstract).
This article has been cited by other articles:
![]() |
S. L. Shafer Anesthesia & Analgesia's Policy on Off-Label Drug Administration in Clinical Trials Anesth. Analg., July 1, 2007; 105(1): 13 - 15. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |